Literature DB >> 29471317

Examining Duration of Protection: Should a Booster Dose Be Part of All Infant Pneumococcal Conjugate Vaccine Programs?

Cynthia G Whitney1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29471317     DOI： 10.1093/cid/ciy135

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

1.  To Boost or Not to Boost? Lessons from the Australian Pneumococcal Conjugate Vaccination Program.

Authors:  Andrew D Wiese; Carlos G Grijalva
Journal:  Clin Infect Dis       Date:  2020-06-10       Impact factor: 9.079

Review 2.  Serotype distribution and antimicrobial resistance patterns of invasive pneumococcal disease isolates from children in mainland China-a systematic review.

Authors:  Weidong Men; Qiaoli Dong; Wei Shi; Kaihu Yao
Journal:  Braz J Microbiol       Date:  2019-12-03       Impact factor: 2.476

Review 3.  Supplying the trip to antibody production-nutrients, signaling, and the programming of cellular metabolism in the mature B lineage.

Authors:  Mark R Boothby; Shawna K Brookens; Ariel L Raybuck; Sung Hoon Cho
Journal:  Cell Mol Immunol       Date:  2021-11-15       Impact factor: 22.096

4.  Persistence of Nasopharyngeal Pneumococcal Vaccine Serotypes and Increase of Nonvaccine Serotypes Among Vaccinated Infants and Their Mothers 5 Years After Introduction of Pneumococcal Conjugate Vaccine 13 in The Gambia.

Authors:  Effua Usuf; Christian Bottomley; Ebrima Bojang; Isatou Cox; Abdoulie Bojang; Rebecca Gladstone; Beate Kampmann; Philip C Hill; Anna Roca
Journal:  Clin Infect Dis       Date:  2019-04-24       Impact factor: 9.079

5.  Decision-making for PCV in adults.

Authors:  John M McLaughlin; David L Swerdlow; Raul E Isturiz; Luis Jodar
Journal:  Hum Vaccin Immunother       Date:  2018-12-10       Impact factor: 3.452

6.  Impact of 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis, Burkina Faso, 2016-2017.

Authors:  Heidi M Soeters; Dinanibè Kambiré; Guetawendé Sawadogo; Rasmata Ouédraogo-Traoré; Brice Bicaba; Isaïe Medah; Lassana Sangaré; Abdoul-Salam Ouédraogo; Soumeya Ouangraoua; Issaka Yaméogo; Malika Congo-Ouédraogo; Absatou Ky Ba; Flavien Aké; Velusamy Srinivasan; Ryan T Novak; Lesley McGee; Cynthia G Whitney; Chris Van Beneden
Journal:  J Infect Dis       Date:  2019-10-31       Impact factor: 5.226
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.